| Dr Mathew Brian Rariden, PSYD, ABPP | |
|
Psc 482, Fpo, AP 96362 | |
| (315) 646-7730 | |
| Not Available |
| Full Name | Dr Mathew Brian Rariden |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | Psc 482, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790815991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 0810004410 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mathew Brian Rariden, PSYD, ABPP Psc 482, Fpo, AP 96362 Ph: (315) 646-1913 | Dr Mathew Brian Rariden, PSYD, ABPP Psc 482, Fpo, AP 96362 Ph: (315) 646-7730 |
News Archive
As world leaders meet this week to review progress and chart the future course of the global AIDS response at the 2011 UN General Assembly High-Level Meeting on AIDS in New York, the International AIDS Society (IAS) calls on leaders to ensure the inclusion of HIV cure research and its global strategy into the international HIV agenda and in all discussions, political decisions and funding strategies.
A new imaging technique could reduce the need for amputation in patients with critical limb ischemia, according to a study publised today in the scientific journal JACC.
Mexicans-Americans born and raised in the United States are more likely to suffer from conditions such as diabetes, high blood pressure and high cholesterol than those who emigrate from Mexico, according to a new study from the University of Southern California.
According to drug company Pfizer the results of two mid-stage studies on its experimental cholesterol drug torcetrapib, combined with its cholesterol drug Lipitor, were so promising that the company will continue into the final stage.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.
› Verified 6 days ago
Daniel Northington, PHD Psychologist Medicare: Medicare Enrolled Practice Location: Nmrtc Okinawa, Psc 482, Fpo, AP 96362 Phone: 805-235-3425 | |
Dr. Odelia Nicole Mcfadden, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Uss Carl Vinson, Unit 100111, Fpo, AP 96629 Phone: 267-709-3521 | |
Allison Conforte, M.ED., ED.S., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s. Nmrtc Yokosuka, Fpo, AP 96350 Phone: 315-243-8649 | |
Dr. Felecia D. Sheffield, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Naf Atsugi Bldg 21, Atsugi, Japan, Fpo, AP 96306 Phone: 315-264-3958 | |
Dr. Ivan Ryota Irie, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5171 | |
Debra Hoffmann Houst, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Medical Department, Uss Carl Vinson Cvn 70, Fpo, AP 96629 Phone: 757-953-5814 | |
Eguono Voke Akpoduado, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s Nmrtc Yokosuka, Naval Hospital, Fpo, AP 96350 Phone: 315-243-8649 |